40762-15-0 Doxefazepam
Nombre del producto |
Doxefazepam |
Nombre en inglés |
Doxefazepam; Doxefazepam [INN]; Sas 643; BRN 0767530; CCRIS 3705; Doxans; Doxefazepamum; Doxefazepamum [INN-Latin]; N-1-Hydroxyethyl-3-hydroxyflurazepam; UNII-231RV72C8L; 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(o-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-; 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-3-hydroxy-1-(2-hydroxyethyl)-2H-1,4-benzodiazepin-2-one; 7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
Fórmula molecular |
C17H14ClFN2O3 |
Peso Molecular |
348.7561 |
InChI |
InChI=1/C17H14ClFN2O3/c18-10-5-6-14-12(9-10)15(11-3-1-2-4-13(11)19)20-16(23)17(24)21(14)7-8-22/h1-6,9,16,22-23H,7-8H2 |
Número de registro CAS |
40762-15-0 |
Estructura Molecular |
|
Densidad |
1.45g/cm3 |
Punto de ebullición |
618.4°C at 760 mmHg |
Índice de refracción |
1.646 |
Punto de inflamación |
327.8°C |
Presión de vapor |
3.77E-16mmHg at 25°C |
Símbolos de Peligro |
|
Códigos de Riesgos |
|
Descripción de Seguridad |
|
|